Cargando…

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Isaacs, JD, Clarke, AM, Hazleman, BL, Hale, G, Waldmann, H, Symmons, DPM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834045/ http://dx.doi.org/10.1186/ar1567

Ejemplares similares

Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.
por: Lamelin, J. P., et al.
Publicado: (1977)

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
por: Matsuno, H, et al.
Publicado: (2003)

Improvement of T-cell function in rheumatoid arthritis (RA) patients in clinical remission is associated with the recovery of IL-7 expression and depends on a familial history of RA
por: Ponchel, F, et al.
Publicado: (2005)

Restricted autologous lymphocytotoxicity in lung neoplasia.
por: Vose, B. M., et al.
Publicado: (1978)

Immunology: Are complement lysis and lymphocytotoxicity analogous?
por: Lachmann, P.J.
Publicado: (1983)

Antibodies to ferritin in rheumatoid arthritis are associated with disease severity
por: Mewar, D, et al.
Publicado: (2005)

T-bet expression in rheumatoid arthritis patients with early, disease-modifying anti-rheumatic drug naïve disease is low and correlates with low levels of IL-7 and T-cell dysfunctions
por: Ponchel, F, et al.
Publicado: (2005)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

The persistence of abnormal T-cell differentiation patterns predicts relapse in rheumatoid arthritis patients with controlled disease
por: Brown, A, et al.
Publicado: (2005)

A revised assay for the measurement of T-cell receptor excision circles as a quantitative measure of thymic function in systemic lupus erythematosus
por: Lorenzi, AR, et al.
Publicado: (2005)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
por: Hughes, J. M., et al.
Publicado: (1989)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

Cytokine pattern in very early rheumatoid arthritis favours B cell activation and survival
por: Moura, R A, et al.
Publicado: (2010)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
por: Hernández, Raquel, et al.
Publicado: (2012)

Prevalence of non-rheumatoid arthritis-associated autoantibodies in sera of anti-cyclic citrulline antibody-positive patients
por: Brozik, M, et al.
Publicado: (2005)

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
por: Lim, Sung Ho, et al.
Publicado: (2022)

Significance of fatigue in patients with rheumatoid arthritis
por: Singh, G, et al.
Publicado: (2003)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Diagnostic value of anticyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis: association with extra-articular manifestations
por: Alexiou, Ioannis, et al.
Publicado: (2007)

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
por: Khare, A. G., et al.
Publicado: (1981)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira, et al.
Publicado: (2015)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Technological and methodical process integration in manufacturing of monoclonal antibodies
por: Gronemeyer, Petra, et al.
Publicado: (2015)

Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
por: Senolt, Ladislav
Publicado: (2019)

Genotype-dependent NOS-3 expression and rheumatoid arthritis
por: Cattaruzza, M, et al.
Publicado: (2005)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Pathogenetic roles of Synoviolin in synovial hyperplasia of rheumatoid arthritis
por: Yamasaki, S, et al.
Publicado: (2003)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
por: Zhizho, Ye, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uhrqrvub8vu043fd6el8st95tf